Biomea Fusion, Inc. SEC filings BMEA

Biomea Fusion, Inc. has 290 filings in SEC EDGAR's recent list, going back to Jan 15, 2021. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.

Biomea Fusion, Inc. SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure, Other events
Oct 14, 2026 Oct 13, 2026
424B5 Prospectus supplement Sep 22, 2026 —
8-K Current report
Other events
Sep 22, 2026 Sep 22, 2026
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report Aug 5, 2026 Aug 5, 2026
8-K Current report
Shareholder vote results
Jun 11, 2026 Jun 10, 2026
10-Q Quarterly report May 11, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 11, 2026 May 11, 2026
8-K Current report
Regulation FD disclosure, Other events
Apr 28, 2026 Apr 27, 2026
DEF 14A Proxy statement Apr 27, 2026 Jun 10, 2026
ARS Annual report to shareholders Apr 27, 2026 Dec 31, 2025
10-K Annual report Mar 24, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 24, 2026 Mar 24, 2026
8-K Current report
Regulation FD disclosure
Feb 25, 2026 Feb 25, 2026
8-K Current report
Regulation FD disclosure, Other events
Jan 14, 2026 Jan 14, 2026
S-8 Employee stock plan registration Jan 6, 2026 —
10-Q Quarterly report Nov 4, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 4, 2025 Nov 4, 2025
8-K Current report
Material agreement, Other events
Oct 7, 2025 Oct 6, 2025
424B5 Prospectus supplement Oct 7, 2025 —
424B5 Prospectus supplement Oct 6, 2025 —
8-K Current report
Other events
Oct 6, 2025 Oct 6, 2025
EFFECT Filing Aug 15, 2025 —
CORRESP Letter to the SEC Aug 13, 2025 —
UPLOAD Letter from the SEC Aug 12, 2025 —
S-3 Shelf registration Aug 5, 2025 —
10-Q Quarterly report Aug 5, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 5, 2025 Aug 5, 2025
8-K Current report
Officer or director change
Jul 24, 2025 Jul 22, 2025
8-K Current report
Material agreement
Jun 20, 2025 Jun 17, 2025
8-K Current report
Material agreement, Other events
Jun 18, 2025 Jun 17, 2025
424B5 Prospectus supplement Jun 18, 2025 —
424B5 Prospectus supplement Jun 17, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Jun 17, 2025 Jun 17, 2025
8-K Current report
Shareholder vote results
Jun 13, 2025 Jun 11, 2025
10-Q Quarterly report May 5, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 5, 2025 May 5, 2025
ARS Annual report to shareholders Apr 28, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 28, 2025 Jun 11, 2025
PRE 14A Preliminary proxy statement Apr 18, 2025 Jun 11, 2025
10-K Annual report Mar 31, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 31, 2025 Mar 31, 2025
8-K Current report
Listing notice, Officer or director change, Regulation FD disclosure
Mar 27, 2025 Mar 25, 2025
8-K Current report
Officer or director change
Feb 28, 2025 Feb 24, 2025
8-K Current report
Other events
Jan 15, 2025 Jan 13, 2025
S-8 Employee stock plan registration Jan 6, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Dec 20, 2024 Dec 17, 2024
8-K Current report
Regulation FD disclosure, Other events
Oct 31, 2024 Oct 30, 2024
10-Q Quarterly report Oct 29, 2024 Sep 30, 2024
8-K Current report
Results of operations
Oct 29, 2024 Oct 29, 2024
8-K Current report
Other events
Sep 27, 2024 Sep 26, 2024
10-Q Quarterly report Jul 31, 2024 Jun 30, 2024
8-K Current report
Results of operations
Jul 31, 2024 Jul 31, 2024
UPLOAD Letter from the SEC Jul 18, 2024 —
CORRESP Letter to the SEC Jun 21, 2024 —
8-K Current report
Shareholder vote results
Jun 12, 2024 Jun 12, 2024
UPLOAD Letter from the SEC Jun 12, 2024 —
8-K Current report
Other events
Jun 7, 2024 Jun 6, 2024
8-K Current report
Results of operations
May 2, 2024 May 2, 2024
10-Q Quarterly report May 2, 2024 Mar 31, 2024
ARS Annual report to shareholders Apr 26, 2024 Dec 31, 2023
DEF 14A Proxy statement Apr 26, 2024 Jun 12, 2024
8-K Current report
Other events
Apr 1, 2024 Apr 1, 2024
8-K Current report
Results of operations
Apr 1, 2024 Apr 1, 2024
10-K Annual report Mar 28, 2024 Dec 31, 2023
8-K Current report
Other events
Mar 7, 2024 Mar 6, 2024
8-K Current report
Other events
Jan 10, 2024 Jan 9, 2024
S-8 Employee stock plan registration Jan 5, 2024 —
10-Q Quarterly report Oct 30, 2023 Sep 30, 2023
8-K Current report
Results of operations
Oct 30, 2023 Oct 30, 2023
10-Q Quarterly report Jul 31, 2023 Jun 30, 2023
8-K Current report
Results of operations
Jul 31, 2023 Jul 31, 2023
8-K Current report
Other events
Jul 25, 2023 Jul 24, 2023
8-K Current report
Shareholder vote results
Jun 15, 2023 Jun 14, 2023
8-K Current report
Other events
May 2, 2023 May 1, 2023
10-Q Quarterly report May 2, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 2, 2023 May 2, 2023
ARS Annual report to shareholders Apr 28, 2023 Dec 31, 2022
DEF 14A Proxy statement Apr 28, 2023 Jun 14, 2023
8-K Current report
Material agreement, Other events
Apr 3, 2023 Mar 29, 2023
424B5 Prospectus supplement Mar 30, 2023 —
424B5 Prospectus supplement Mar 29, 2023 —
8-K Current report
Regulation FD disclosure, Other events
Mar 28, 2023 Mar 28, 2023
10-K Annual report Mar 28, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 28, 2023 Mar 28, 2023
8-K Current report
Other events
Jan 12, 2023 Jan 9, 2023
S-8 Employee stock plan registration Jan 4, 2023 —
8-K Current report
Other events
Dec 16, 2022 Dec 14, 2022
8-K Current report
Other events
Dec 13, 2022 Dec 12, 2022
8-K Current report
Material agreement
Nov 25, 2022 Nov 25, 2022
424B5 Prospectus supplement Nov 25, 2022 —
10-Q Quarterly report Nov 7, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 7, 2022 Nov 7, 2022
8-K Current report
Other events
Nov 1, 2022 Oct 31, 2022
EFFECT Filing Oct 24, 2022 —
CORRESP Letter to the SEC Oct 20, 2022 —
UPLOAD Letter from the SEC Oct 19, 2022 —
8-K Current report
Other events
Oct 18, 2022 Oct 14, 2022
S-3 Shelf registration Oct 14, 2022 —
8-K Current report
Other events
Sep 23, 2022 Sep 22, 2022
8-K Current report
Other events
Sep 22, 2022 Sep 20, 2022
8-K Current report
Material agreement, New debt
Sep 9, 2022 Sep 7, 2022
8-K Current report
Other events
Aug 29, 2022 Aug 26, 2022
10-Q Quarterly report Aug 1, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 1, 2022 Aug 1, 2022
8-K Current report
Shareholder vote results
Jun 23, 2022 Jun 22, 2022
8-K Current report
Other events
Jun 6, 2022 Jun 4, 2022
10-Q Quarterly report May 16, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 16, 2022 May 16, 2022
DEFA14A Additional proxy material Apr 29, 2022 —
DEF 14A Proxy statement Apr 29, 2022 Jun 22, 2022
8-K Current report
Officer or director change
Apr 22, 2022 Apr 19, 2022
8-K Current report
Other events
Apr 8, 2022 Apr 8, 2022
10-K Annual report Feb 28, 2022 Dec 31, 2021
8-K Current report
Results of operations
Feb 28, 2022 Feb 28, 2022
S-8 Employee stock plan registration Feb 2, 2022 —
8-K Current report
Regulation FD disclosure
Jan 12, 2022 Jan 12, 2022
8-K Current report
Regulation FD disclosure
Nov 15, 2021 Nov 11, 2021
10-Q Quarterly report Nov 3, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 3, 2021 Nov 3, 2021
8-K Current report
Other events
Sep 17, 2021 Sep 16, 2021
10-Q Quarterly report Aug 11, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 11, 2021 Aug 11, 2021
8-K Current report
Regulation FD disclosure
Jul 19, 2021 Jul 19, 2021
8-K/A Amended current report
Officer or director change
Jul 12, 2021 Jul 7, 2021
8-K Current report
Officer or director change
Jul 9, 2021 Jul 7, 2021
8-K Current report
Officer or director change
Jun 29, 2021 Jun 28, 2021
8-K Current report
Officer or director change
Jun 17, 2021 Jun 16, 2021
10-Q Quarterly report May 27, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 27, 2021 May 27, 2021
S-8 Employee stock plan registration Apr 20, 2021 —
8-K Current report
Bylaw or fiscal year change, Other events
Apr 20, 2021 Apr 20, 2021
424B4 Prospectus Apr 19, 2021 —
EFFECT Filing Apr 15, 2021 —
S-1MEF Filing Apr 15, 2021 —
CERT 8a certification Apr 15, 2021 —
S-1/A Amended registration statement Apr 15, 2021 —
CORRESP Letter to the SEC Apr 15, 2021 —
UPLOAD Letter from the SEC Apr 15, 2021 —
8-A12B Filing Apr 14, 2021 —
CORRESP Letter to the SEC Apr 13, 2021 —
CORRESP Letter to the SEC Apr 13, 2021 —
CORRESP Letter to the SEC Apr 12, 2021 —
S-1/A Amended registration statement Apr 12, 2021 —
UPLOAD Letter from the SEC Apr 2, 2021 —
CORRESP Letter to the SEC Mar 26, 2021 —
S-1 Registration statement Mar 26, 2021 —
UPLOAD Letter from the SEC Mar 12, 2021 —
DRS Filing Feb 12, 2021 —
D Filing Jan 15, 2021 —

Showing 150 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
BMEA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Carlos, CA
SEC filer status
, Emerging growth company
SEC CIK
1840439

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.